Search Results - P. Nozza

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    DP091 | EFFICACY OF CPX-351 IN SECONDARY ACUTE MYELOID LEUKEMIA DEFINED ACCORDING TO WHO 2022 CLASSIFICATION. by F. Guolo, C. Riva, S. Nicoletta, R. Romei, G. Zecchetti, E. Maio, Y. Azzanelli, N. Colombo, S. Rosellini, A. Parodi, E. Tedone, E. Carminati, F. Puglisi, C. Nurra, G. Fugazza, P. Nozza, M. Cea, R.M. Lemoli

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  2. 2

    DP031 | PROGNOSTIC IMPACT OF HIGH-RISK MUTATIONS IN SECONDARY AML TREATED WITH CPX-351: A FOCUS ON MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL by C. Riva, P. Minetto, S. Nicoletta, R. Romei, M. Chies, G. Zecchetti, E. Maio, Y. Azzanelli, N. Colombo, S. Rosellini, A. Parodi, E. Tedone, E. Carminati, F. Puglisi, C. Nurra, G. Fugazza, P. Nozza, M. Cea, R.M. Lemoli, F. Guolo

    Published in Haematologica (2025-09-01)
    Get full text
    Article


Search Tools: